Deutsche Bank on Monday reduced its price target on Danish drugmaker Novo (NOVO-B.CO) to 245 Danish kroner from 265 kroner and maintained its sell rating.
What else is happening in Research?
Research
Lake Street Downgrades Priority Technology to Hold From Buy, $8.05 Price Target
Priority Technology (PRTH) has an average rating of buy and mean price target of $10.80, according to analysts polled by FactSet.Price: $7.76, Change: $+1.93, Percent Change: +33.10%
$PRTH
Research
Tecsys Price Target Raised to CA$46.00 at ATB
ATB Cormark Capital Markets raised its price target on Tecsys Inc. (TCS.TO) to CA$46.00 from CA$41.00 on Monday.Analyst Gavin Fairweather maintained an outperform rating on shares of the enterprise supply-chain management software company."Last week, we attended meetings with TCS CEO Peter Brereton and institutional investors," Fairweather said in a note to clients."The interactions reinforced our view that strengthening bookings, growth and margins are durable trends over our forecast horizon," the analyst said.
$TCS.TO
Research
Deutsche Bank Kicks Off Vincorion Coverage at Buy
Deutsche Bank on Monday initiated the coverage of German defense and security systems developer Vincorion (V1NC.F) with a buy rating and a price target of 26 euros.
$V1NC.F